StockWatch
·

JENBURKT PHARMACEUTICALS LTD. Q4 FY25 Results

JENBURPHQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue41.0511.3%
Total Income42.9311.6%
Expenditure31.097.3%
PBT11.8424.4%
Net Profit8.5431.2%
OPM26.45%7.36pp
NPM19.89%2.98pp
EPS19.3431.1%
View full financials

Informational and educational content only. Not investment advice.